A look at the prevalence of placebo response in clinical trials and how advanced solutions can mitigate the risk it poses to drug development.
Erica Smith, PhD
Advertisement
Chief Business Officer, Cognivia
Articles by Erica Smith, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Praxis Reports Positive Phase III Results for Ulixacaltamide in Essential Tremor
2
Adaptive Trial Design as a Pathway to Faster Development
3
Setting the Limits of Autonomy with Autonomous Agents for Clinical Research
4
Imfinzi Plus FLOT Significantly Improves Overall Survival in Gastric and Gastroesophageal Cancer
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
